Biolinq Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Biolinq's estimated annual revenue is currently $27.9M per year.(i)
  • Biolinq's estimated revenue per employee is $251,000

Employee Data

  • Biolinq has 111 Employees.(i)
  • Biolinq grew their employee count by 18% last year.

Biolinq's People

NameTitleEmail/Phone
1
Co-Founder, President & CTOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP QualityReveal Email/Phone
4
VP Corporate DevelopmentReveal Email/Phone
5
VP Sensor R&D and Advanced ResearchReveal Email/Phone
6
VP, Product StrategyReveal Email/Phone
7
SVP, R&DReveal Email/Phone
8
Director Information TechnologyReveal Email/Phone
9
Technical DirectorReveal Email/Phone
10
Director, Sensor ChemistryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Biolinq?

Biolinq is a startup that has developed a proprietary wearable biosensor platform that is capable of measuring blood level information, without the need to draw blood. We are developing products that are changing the way patients and consumers access information about their body, by making new levels of actionable information readily available. We are dedicated to the personal and professional growth of all our team members and strive to create a positive and creative work environment.

keywords:N/A

N/A

Total Funding

111

Number of Employees

$27.9M

Revenue (est)

18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Biolinq News

2022-04-19 - Continuous Glucose Monitoring Systems Market Size, Scope ...

Medtronic PLC, Sano Intelligence, Biolinq, Echo Therapeutics, Pfizer, Baxter, Animas. Market factors could use prospect information to attract informed...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.3M111-10%N/A
#2
$17.2M1117%$175M
#3
$39.2M111-1%N/A
#4
$22.8M111-6%N/A
#5
$35M1114%N/A